CoChat

Probiotics and the Treatment of Parkinson's Disease: An Update

Open access

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Abstract

Parkinson's disease (PD) is a progressive neurological disorder characterized by motor and non-motor features. Although some progress has been made in conventional PD treatments, these breakthroughs have yet to show high efficacy in treating this neurodegenerative disease. Probiotics are live microorganisms that confer health benefits on the host when administered in adequate amounts. Probiotics have putative anticancer, antioxidative, anti-inflammatory, and neuroprotective effects. Multiple lines of evidence show that probiotics control and improve several motor and non-motor symptoms in patients and experimental animal models of PD. Probiotic supplementation mediates these pharmacological effects by targeting a variety of cellular and molecular processes, i.e., oxidative stress, inflammatory and anti-inflammatory pathways, as well as apoptosis. Herein, we summarize the effects of probiotics on motor and non-motor symptoms as well as various cellular and molecular pathways in PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10571-021-01128-w

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 91 references

Research works printed but not linked: 1

  1. Mirzanaeni S, Pakpour B, Navabian M (2019) The treatment effect of probiotic Bacillus coagulans on male Parkinson’s rats. J Appl Microbiol Food Ind 5(3):17–30

Cited by

See all 62

Metadata

Authors
Mirzaei, H., Sedighi, S., Kouchaki, E., Barati, E., Dadgostar, E., Aschner, M., & Tamtaji, O. R.
Affiliations
  • Kashan University of Medical Sciences (IR)
  • Islamic Azad University, Tehran (IR)
  • Isfahan University of Medical Sciences (IR)
  • Albert Einstein College of Medicine (US)
Corresponding author
Tamtaji, Omid Reza
Venue
Cellular and Molecular Neurobiology
Published
2021-07-20
Volume
42
Issue
8
Pages
2449-2457
ISSN
  • 0272-4340 (ISSN-L)
  • 1573-6830
OpenAlex
W3185323608
Cited by
57
References
91
Citations by year
2026: 13 · 2025: 15 · 2024: 18 · 2023: 6 · 2022: 4 · 2021: 1
FWCI
0.93
Type
journal article
Language
en
Open access
Licence
Locations
  • Cellular and Molecular Neurobiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Environmental Health Sciences (R01ES007331, R01ES010563)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
probiotics, Parkinson's disease, neuroprotection, oxidative stress, neuroinflammation, apoptosis, motor symptoms, non-motor symptoms, gut-brain axis, anti-inflammatory activity, antioxidant activity
MeSH terms
Animals, Anti-Inflammatory Agents, Parkinson Disease, Neuroprotective Agents, Neurodegenerative Diseases, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics and the Treatment of Parkinson's Disease: An Update. https://app.cochat.ai/papers/10.1007/s10571-021-01128-w
The paper
Mirzaei, H., Sedighi, S., Kouchaki, E., Barati, E., Dadgostar, E., Aschner, M., & Tamtaji, O. R. (2022). Probiotics and the Treatment of Parkinson's Disease: An Update. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-021-01128-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.